Evidence map›Paper›PMID 22352897›Full record

ReviewBritish journal of pharmacology2012

Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia.

Marta Armogida, Robert Nisticò, Nicola Biagio Mercuri

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Iranian journal of basic medical sciences · 2026
    Article
  3. Article
  4. Article
  5. Biology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. ACTH(6-9)PGP Peptide Protects SH-SY5Y Cells from HMolecules (Basel, Switzerland) · 2021
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Neuroprotective Effect of CeONeurochemical research · 2018
    Article
  18. Review
  19. The Role of CaNeurochemical research · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Marta ArmogidaLaboratory of Experimental Neurology, Fondazione Santa Lucia IRCCS, Rome, Italy.
Robert Nisticò
Nicola Biagio Mercuri
Istituti di Ricovero e Cura a Carattere Scientifico · ITFondazione Santa Lucia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For many years after its discovery, hydrogen peroxide (H₂O₂) was viewed as a toxic molecule to human tissues; however, in light of recent findings, it is being recognized as an ubiquitous endogenous molecule of life as its biological role has been better elucidated. Indeed, increasing evidence suggests that H₂O₂ may act as a second messenger with a pro-survival role in several physiological processes. In addition, our group has recently demonstrated neuroprotective effects of H₂O₂ on in vitro and in vivo ischaemic models through a catalase (CAT) enzyme-mediated mechanism. Therefore, the present review summarizes experimental data supporting a neuroprotective potential of H₂O₂ in ischaemic stroke that has been principally achieved by means of pharmacological and genetic strategies that modify either the activity or the expression of the superoxide dismutase (SOD), glutathione peroxidase (GPx) and CAT enzymes, which are key regulators of H₂O₂ metabolism. It also critically discusses a translational impact concerning the role played by H₂O₂ in ischaemic stroke. Based on these data, we hope that further research will be done in order to better understand the mechanisms underlying H₂O₂ functions and to promote successful H₂O₂ signalling based therapy in ischaemic stroke.

Indexed as

Molecular Targeted TherapyAnimalsAntioxidantsBrain IschemiaCorpus StriatumDisease Models, AnimalEnzyme InhibitorsHippocampusHumansHydrogen PeroxideNeuronsNeuroprotective AgentsOxidoreductasesReperfusion InjurySignal TransductionSubstantia NigraAntioxidantsEnzyme InhibitorsHydrogen PeroxideNeuroprotective AgentsOxidoreductases

Identifiers

PMID22352897
PMCPMC3417441
OpenAlexW1576610428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.